A pioneering treatment that prevents cancer patients from losing their hair whilst undergoing chemotherapy is now available in the Middle East.
The British developed Paxman Cooling System (also known as the ‘cold cap’) alleviates the damage causes to the hair follicle by chemotherapy. It works by reducing the temperature of the scalp by a few degrees immediately before, during and after the administration of chemotherapy.
Made from lightweight, silicone, the scalp cooling cap is soft and flexible – providing a snug, yet comfortable cap during treatment. Moulding to all head shapes and sizes, liquid coolant passes through the cap extracting heat from the patient’s scalp, ensuring it remains at an even, constant temperature to minimise hair loss.
The innovative technology, which will be display at Arab Health 2018, has been developed by a British family who understand what it is like to lose hair due to cancer treatment. The concept came when mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy induced hair loss.
The company has since been on a personal journey to ensure Sue’s legacy lives on by helping women around the globe minimise chemotherapy-induced hair loss and contribute to their quality of life. In the Middle East they are working with a new partner AKI Healthcare (ALPHAMED) to ensure that it is available to Middle Eastern cancer patients.
Richard Paxman, CEO at Paxman said: “Chemotherapy induced hair loss is consistently ranked in the top five most distressing cancer chemotherapy side effects and we are working hard to ensure that cancer patients have a choice against hair loss. We are delighted to be able to offer scalp cooling to Middle Eastern patients.”
Chemotherapy works by targeting all rapidly dividing cells in the body. Hair is the second fastest dividing cell, and this is the reason why many chemotherapy drugs cause alopecia. The hair follicles in the growth phase are attacked, resulting in hair loss approximately two weeks after the commencement of chemotherapy treatment.
Fadi Dababneh, Sales Manager of ALPHAMED added: “With 30 years of experience we have mastered the recipe for success by partnering with the best companies in the sector to bring the latest cutting-edge technology to the UAE market, and Paxman is no exception. We are proud to be a part of this therapy, which serves a window of hope to chemotherapy patients and help them gain control through their treatment plan to defeat cancer.”
The Paxman Scalp Cooling System is the world-leading hair loss prevention system for chemotherapy patients. It has been used by over 100,000 patients, in 32 countries and is responsible for helping patients to keep their hair and retain a feeling of normality during chemotherapy.
The Arab Health Exhibition & Congress is taking place from 29th January to the 1st February 2018, at the Dubai Convention and Exhibition Centre. Throughout the exhibition the Paxman Scalp Cooler will be located on the Leeds City Region (stand P.D12 located in the Pavilion.
To find out more about scalp cooling visit www.paxmanscalpcooling.com
